The Global Hematological Malignancies Drugs Market is valued at US$ 13.76 Billion in 2021, and it is expected to reach US$ 42.78 Billion by 2028, with a CAGR of 13 % during the forecast period of 2022-2028. Hematological malignancies such as lymphoma, leukemia, and multiple myeloma are cancers of blood-forming cells. These cells consist of platelets for wound clotting, […]
